STADA Arzneimittel financials at a glance
| Year | Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
2.33€B | 2.61€B | 3.01€B | 3.25€B | 3.80€B | 0.00€M |
| GM % | Gross Margin % |
|
51.11% | 52.49% | 49.82% | 47.52% | 48.69% | 0.00% |
| OM | Operating Margin |
|
17.14% | 17.86% | 16.37% | 15.77% | 16.64% | 0.00% |
| EPS | Earnings Per Share |
|
0.00€ | |||||
| Div. | Dividends |
|
0.00€ | 0.00€ | 0.00€ | 0.00€ | 0.00€ | 0.00€ |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
62.26m | 62.26m | 0m | 0m | 0m | 0m |
| OCF | Operating Cash Flow |
|
320.29€M | 444.08€M | 405.89€M | 598.25€M | 738.59€M | 0.00€M |
| FCF | Free Cash Flow |
|
272.23€M | 361.36€M | 341.16€M | 519.61€M | 664.76€M | 0.00€M |
| FCFS | Free Cash Flow Per Share |
|
-0.11€ | 3.21€ | -1.48€ | 4.56€ | 7.94€ | 0.00€ |